Somatuline Autogel To Be Promoted By Tercica
Tercica gains the rights to the acromegaly treatment in the U.S. and Canada through a cross-licensing agreement with Ipsen, which receives European rights to Increlex.
Tercica gains the rights to the acromegaly treatment in the U.S. and Canada through a cross-licensing agreement with Ipsen, which receives European rights to Increlex.